Minglun Wang is a scientist currently working at Beam Therapeutics since May 2021, specializing in gene therapy, base editing, off-target analysis and de-risking, and next-generation sequencing (NGS). Previously, Minglun served as a Senior Research Associate II at Homology Medicines, Inc. from December 2018 to May 2021, focusing on AAV gene therapy. Minglun's extensive experience also includes a role as Sr. Principal Researcher at Eisai from November 2002 to November 2018, and positions as a Sr. Research Biologist at Alethia BioTherapeutics Inc. in Montreal, and as a Technical Officer level 3 at the National Research Council Canada. Earlier career experience includes work as a Research Biologist at McGill University. Minglun holds two master's degrees in Microbiology and Immunology from the University at Buffalo and Nanjing Medical University, and a bachelor's degree in Virology from Wuhan University.
This person is not in any teams
This person is not in any offices